K. Michael Conaway sold Monsanto Company (MON) (MON)
K. Michael Conaway sold MON · disclosed November 6, 2014
K. Michael Conaway, a TX House member representing District 11, sold $1,001 - $15,000 of Monsanto Company (MON) (MON) on September 30, 2014. Filings associated with K. Michael Conaway disclosed 0 other MON transactions in the 12 months before this trade. Shares of MON have risen 42.9% since the first observed purchase on September 30, 2014. The filing was publicly disclosed on November 6, 2014; a direct filing link is not available in the current data record.
Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For K. Michael Conaway's complete filing history, visit K. Michael Conaway's full trade history. Browse all trading members of Congress tracked by Quantellect.
Key points
- K. Michael Conaway sold MON in the amount range of $1,001 - $15,000 on September 30, 2014, filed under the STOCK Act.
- The filing lists Spouse as the transaction owner and was disclosed 37 days after the trade.
- The asset description in the filing reads 'Monsanto Company (MON).'
- Filings associated with K. Michael Conaway disclosed 0 other MON transactions in the 12 months before this trade.
- Shares of MON have risen 42.9% since the first observed purchase on September 30, 2014.
Did K. Michael Conaway buy or sell MON?
The Periodic Transaction Report covers a single sale involving MON on September 30, 2014. The filed amount range is $1,001 - $15,000. The asset description reads 'Monsanto Company (MON)', as submitted by the filer. The report was submitted on November 6, 2014. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.
| Politician | Action | Ticker | Amount | Trade date | Filed |
|---|---|---|---|---|---|
| K. Michael Conaway (House) | Sell | MON | $1,001 - $15,000 | September 30, 2014 | November 6, 2014 |
What other MON trades has K. Michael Conaway disclosed in the past 12 months?
Filings associated with K. Michael Conaway disclosed 0 other MON transactions in the 12 months before this trade.
| Trade date | Action | Owner | Amount | Filing |
|---|---|---|---|---|
| No other MON transactions were disclosed in the prior 12 months. | ||||
What does the filing show, and what does it not show?
The filing reports a sale involving MON by K. Michael Conaway in the amount range of $1,001 - $15,000, with Spouse listed as the owner. It does not establish K. Michael Conaway's total holdings in MON, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'Monsanto Company (MON)', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify K. Michael Conaway's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with K. Michael Conaway disclosed 0 other MON transactions in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.
Who else in Congress traded MON?
Quantellect's current database lists these recent MON disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.
| Member | Party | Action | Amount | Disclosed |
|---|---|---|---|---|
| No recent disclosures by other members are available. | ||||
How has K. Michael Conaway's disclosed trading performed?
A current measured Member Score is not available for this member. Quantellect does not infer performance where the scored-trade projection lacks coverage.
All K. Michael Conaway MON trades
Frequently asked questions
Did K. Michael Conaway buy or sell MON?
According to the disclosure, K. Michael Conaway sold MON on September 30, 2014.
What amount was reported for the MON transaction?
The disclosure reports $1,001 - $15,000 for the sale. Filed amounts are ranges, not exact transaction values.
When did the transaction occur, and when was it disclosed?
The transaction is dated September 30, 2014, and it was disclosed on November 6, 2014.
Where can I see K. Michael Conaway's other congressional trades?
Quantellect lists K. Michael Conaway's complete disclosed trade history on the member profile. K. Michael Conaway's trade history
Is congressional stock trading legal?
The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act
Is Congress exempt from insider trading laws?
No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act
How quickly must members of Congress disclose a trade?
Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance
How is net worth reported in these disclosures?
It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act
Browse all members of Congress who trade stocks·See which stocks Congress trades·Congressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.

